Frontlight ResearchEarly access
Trial site
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Ematologia
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Follicular lymphoma2 trials
- Mantle cell lymphoma1 trial
- Phase
- Phase 22 trials
- Status
- Active, not recruiting1 trial
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Fondazione Italiana Linfomi - ETS3 trials
Running trials
Not yet recruiting
PirtobrUtinib as Frontline Therapy for Elderly Unfit/Frail Patient With MAntle Cell Lymphoma
Active, not recruiting
Study With Mosunetuzumab and Zanubrutinib in R/R Follicular Lymphoma Patients
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Follicular lymphoma1 recruiting
- Mantle cell lymphoma1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026